Whole-genome expression analyses identified chemokine (C–C motif) ligand 2 (CCL2) as the top-listed NF-κB-regulated gene that was increased in glioblastoma cells by Smac mimetic treatment24. The gene discussed is NFKB1; the disease is glioblastoma.